Evidence map›Paper›PMID 32348444›Full record

ArticleJournal of applied oral science : revista FOB2020

Perillyl alcohol has antibacterial effects and reduces ROS production in macrophages.

Rebeca Dantas Alves Figueiredo, Adriana Cabrera Ortega, Laura Andrea González Maldonado, Ricardo Dias de Castro, Mario Julio Ávila-Campos, Carlos Rossa, Sabrina Garcia de Aquino

Open access · diamondAbstract readEvaluation Study
In one paragraph

Article in Journal of applied oral science : revista FOB, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. The Antiviral Potential ofMolecules (Basel, Switzerland) · 2024
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Emerging strategies for combatingExploration (Beijing, China) · 2024
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Rebeca Dantas Alves FigueiredoPrograma de Pós-Graduação em Odontologia, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brasil.
Adriana Cabrera OrtegaDepartamento de Diagnóstico e Cirurgia, Faculdade de Odontologia de Araraquara, Universidade Estadual Paulista, Araraquara, São Paulo, Brasil.
Laura Andrea González MaldonadoDepartamento de Diagnóstico e Cirurgia, Faculdade de Odontologia de Araraquara, Universidade Estadual Paulista, Araraquara, São Paulo, Brasil.
Ricardo Dias de CastroPrograma de Pós-Graduação em Odontologia, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brasil.
Mario Julio Ávila-CamposDepartamento de Microbiologia, Instituto de Ciências Biológicas, Universidade de São Paulo, São Paulo, Brasil.
Carlos RossaDepartamento de Diagnóstico e Cirurgia, Faculdade de Odontologia de Araraquara, Universidade Estadual Paulista, Araraquara, São Paulo, Brasil.
Sabrina Garcia de AquinoPrograma de Pós-Graduação em Odontologia, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brasil.
Universidade Estadual Paulista (Unesp) · BRUniversidade Federal da Paraíba · BRUniversidade Brasil · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products have emerged as a rich source of bioactive compounds for adjunctive treatments of many infectious and inflammatory conditions, including periodontitis. Among the monoterpenes with significant biological properties, there is the perillyl alcohol (POH), which can be found in several essential oils and has shown immunomodulatory properties in recent studies, which may be interesting in the treatment of non-neoplastic inflammatory disorders. Objective To determine the antibacterial and immune modulatory activities of the POH. Methodology The minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) of the POH for two significant Gram-negative periodontal pathogens were determined by macrodilution and subculture, respectively. Cell proliferation and cytotoxicity in RAW 264.7 macrophages were determined by Trypan Blue and mitochondrial enzymatic activity assay. The modulation of reactive oxygen species (ROS) was analyzed by flow cytometry and expression of TNF and arginase-1 by real-time PCR. Results The POH was effective against P. gingivalis (ATCC 33277) and F. nucleatum (ATCC 25586) with MIC= MBC=1600 μM. No cytotoxicity up to 100 µM was observed on macrophages. The cell proliferation was inhibited from 48 hours at 100 μM (p<0.05) and 250 μM (p<0.01). The POH increased ROS production at both 10 μM and 100 μM (p<0.05) in unstimulated cells. The PMA-induced ROS production was not affected by POH, whereas 100 μM significantly reduced lipopolysaccharide-induced (LPS-induced) ROS. The expression of TNF was not affected by POH in unstimulated cells or in cells polarized to M1 phenotype, whereas both concentrations of POH reduced (p<0.05) the expression of arginase-1 in M2-polarized macrophages. Conclusion The POH has antibacterial activity against periodontal pathogens and reduced proliferation of murine macrophages without significant cytotoxicity at concentrations up to 100 μM. In addition, the POH reduced the LPS-induced ROS and the expression of arginase-1 in M2-polarized macrophages.

Indexed as

AnimalsAnti-Bacterial AgentsArginaseBiological ProductsCell ProliferationFlow CytometryFusobacterium nucleatumGene ExpressionLipopolysaccharidesMacrophagesMiceMicrobial Sensitivity TestsMonoterpenesPorphyromonasRAW 264.7 CellsReactive Oxygen SpeciesAnti-Bacterial AgentsArginaseBiological ProductsLipopolysaccharidesMonoterpenesperillyl alcoholReactive Oxygen SpeciesTumor Necrosis Factor-alpha

Identifiers

PMID32348444
PMCPMC7185983
OpenAlexW3020530887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.